Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Guerrot

Showing results (21-30 of 135) with videos related to

Pageof 14
Sort By:
Expert Opinion on Drug Discovery|February 5, 2014
Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseasesThomas Duflot, Clothilde Roche, Fabien Lamoureux, et al.
Nephrologie & Therapeutique|December 25, 2016
[French translation of the clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3B or higher (eGFR<45mL/min/1.73 m<sup>2</sup>)]Noémie Jourde-Chiche, Dominique Guerrot, Dominique Chauveau, et al.
Nephrologie & Therapeutique|May 9, 2015
[Travel memories]Charlotte Laurent, Arnaud François, Frank Le Roy, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 15, 2010
Acute renal failure and Fanconi syndrome due to deferasiroxSteven Grangé, Dominique M Bertrand, Dominique Guerrot, et al.
BMC Nephrology|May 28, 2013
Monitoring of hemodialysis quality-of-care indicators: why is it important?Steven Grangé, Mélanie Hanoy, Frank Le Roy, et al.
Journal of Nephrology|December 23, 2017
Monoclonal B lymphocytosis and minimal change disease: a new monoclonal B-cell disorder of renal significance?Margaux Van Wynsberghe, Pascal Lenain, Fanny Drieux, et al.
Nephrologie & Therapeutique|April 26, 2023
Cardio-renal syndrome: what’s new in 2023?Valentin Maisons, Mouad Hamzaoui, Mélanie Hanoy, et al.
Pharmacology & Therapeutics|December 8, 2024
Glucuronidation of orally administered drugs and the value of nanocarriers in strategies for its overcomeLaura Hervieu, Anne-Claire Groo, Jérémy Bellien, et al.
Bulletin De L'Academie Nationale De Medecine|July 30, 2010
[Role of cell plasticity in progression and regression of renal fibrosis]Jean-Claude Dussaule, Dominique Guerrot, Anne-Cécile Huby, et al.
Clinical Kidney Journal|November 16, 2022
Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccineTristan de Nattes, Sophie Candon, Véronique Lemée, et al.
Pageof 14

Showing results (21-30 of 135) with videos related to

Sort By:
Pageof 14
Expert Opinion on Drug Discovery|February 5, 2014
Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseasesThomas Duflot, Clothilde Roche, Fabien Lamoureux, et al.
Nephrologie & Therapeutique|December 25, 2016
[French translation of the clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3B or higher (eGFR<45mL/min/1.73 m<sup>2</sup>)]Noémie Jourde-Chiche, Dominique Guerrot, Dominique Chauveau, et al.
Nephrologie & Therapeutique|May 9, 2015
[Travel memories]Charlotte Laurent, Arnaud François, Frank Le Roy, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 15, 2010
Acute renal failure and Fanconi syndrome due to deferasiroxSteven Grangé, Dominique M Bertrand, Dominique Guerrot, et al.
BMC Nephrology|May 28, 2013
Monitoring of hemodialysis quality-of-care indicators: why is it important?Steven Grangé, Mélanie Hanoy, Frank Le Roy, et al.
Journal of Nephrology|December 23, 2017
Monoclonal B lymphocytosis and minimal change disease: a new monoclonal B-cell disorder of renal significance?Margaux Van Wynsberghe, Pascal Lenain, Fanny Drieux, et al.
Nephrologie & Therapeutique|April 26, 2023
Cardio-renal syndrome: what’s new in 2023?Valentin Maisons, Mouad Hamzaoui, Mélanie Hanoy, et al.
Pharmacology & Therapeutics|December 8, 2024
Glucuronidation of orally administered drugs and the value of nanocarriers in strategies for its overcomeLaura Hervieu, Anne-Claire Groo, Jérémy Bellien, et al.
Bulletin De L'Academie Nationale De Medecine|July 30, 2010
[Role of cell plasticity in progression and regression of renal fibrosis]Jean-Claude Dussaule, Dominique Guerrot, Anne-Cécile Huby, et al.
Clinical Kidney Journal|November 16, 2022
Humoral response to a fourth dose of mRNA vaccine in kidney transplant recipient responders to three doses of mRNA vaccineTristan de Nattes, Sophie Candon, Véronique Lemée, et al.
Pageof 14